Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma

High-dose methotrexate (HD-MTX) at 3 g/m(2) is one of the strategies for central nervous system (CNS) prophylaxis in the first-line treatment of aggressive lymphomas, especially in diffuse large B cell lymphoma patients with high-risk CNS-International Prognostic Index. The objective of our study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, S., Hachon, L., Diasonama, J. F., Madaoui, C., Aguinaga, L., Miekoutima, E., Moatti, H., Perrial, Emeline, Madelaine, I., Brice, P., Thieblemont, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960588/
https://www.ncbi.nlm.nih.gov/pubmed/33608849
http://dx.doi.org/10.1007/s00277-020-04341-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960588/
https://www.ncbi.nlm.nih.gov/pubmed/33608849
http://dx.doi.org/10.1007/s00277-020-04341-7

Ejemplares similares